1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2023
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2021
-
Mark
IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
- 2016
-
Mark
CD4(+) CD56(+) natural killer T-like cells secreting interferon-γ are associated with incident coronary events.
(
- Contribution to journal › Article
- 2013
-
Mark
T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke.
2013) In Arteriosclerosis, Thrombosis and Vascular Biology(
- Contribution to journal › Article